Betterbrand, a company focused on respiratory wellness, has announced the launch of its new lung support formula, BetterLungsTM, which has been validated through clinical research. Founded by pharmacist Dr. Chris Jackson, Betterbrand aims to provide natural respiratory solutions inspired by personal family experiences with smoking-related illnesses.
The creation of BetterLungsTM is deeply personal for Dr. Jackson, whose grandmother and two aunts succumbed to respiratory complications linked to smoking. This tragic background has motivated him to develop a product that offers natural support for lung health without the side effects commonly associated with traditional medications.
The formula combines ingredients such as mullein and chlorophyll, both known for their potential benefits in aiding mucus clearance and alleviating coughs. Clinical validation was achieved through a 60-day triple-blind, placebo-controlled trial conducted in 2025, a rigorous methodology that ensures unbiased results.
Key findings from the trial reveal that participants using the Mullein + Chlorophyll Tincture experienced a statistically significant reduction in fatigue, with an impressive 30% decrease compared to the placebo group. The outcomes of the study indicate effectiveness in enhancing respiratory wellness, particularly among users of BetterLungsTM.
Trial Results Highlight Impact on Respiratory Health
Participants in the clinical trial reported a range of positive changes in their respiratory health. Notably, 81% of individuals experienced reduced coughing, while 79% noted clearer airways. Additionally, 76% of participants reported less mucus buildup, contributing to an overall improved quality of breathing.
Further highlights from the trial include:
– Enhanced energy levels and decreased fatigue
– More comfortable and deeper breathing
– Easier mucus clearance
– Less frequent coughing episodes
– Reduced feelings of breathlessness
These promising results underscore the potential of BetterLungsTM to make a meaningful impact on the lives of individuals seeking natural respiratory support.
The success of this product is particularly significant given that nearly 80% of clinical trials are abandoned due to inconclusive or unfavorable results. The rigorous nature of this study reinforces the credibility of the findings and suggests a new avenue for those looking for alternatives in respiratory health management.
As Betterbrand continues to advance its mission, the launch of BetterLungsTM represents not only a business achievement but also a personal tribute to the founder’s family legacy. The company is poised to make a difference in the lives of many, fostering a shift towards natural solutions for respiratory wellness.
